Search clinical trials for: Placebo drug

Total 265550 results

Pfizer
Yale University

Completed

Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects

Healthy

United States
Impax Laboratories, LLC
AstraZeneca

Completed

Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE

Migraine

United States
AstraZeneca

Completed

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Type 2 Diabetes

Japan
Association of Urologic Oncology (AUO)
University Hospital, Essen

Terminated

Sorafenib in Urothelium Cancer of Bladder

Bladder Cancer
Cerevel Therapeutics, LLC

Completed

A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants

Major Depressive Disorder

United States
Abhimanyu Garg

Completed

Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

Familial Partial Lipodystrophy

United States
CONRAD
RTI International; Match Research; UZ-UCSF Collaborative Research Programme

Completed

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

HIV | Contraception

South Africa, Zimbabwe
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Hematopoietic and Lymphoid Cell Neoplasm | Myelofibrosis | Chronic Lymphocytic Leukemia | Adult Acute Myeloid Leukemia in Remission | Myelodysplastic Syndrome | Adult Acute Lymphoblastic Leukemia in Remission | Myeloproliferative Neoplasm | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditions

United States
Galderma R&D

Completed

Effect of CD07805/47 Gel in Rosacea Flushing

Rosacea

Germany
Mabwell (Shanghai) Bioscience Co., Ltd.

Active, not recruiting

An Evaluation of 9MW1911 Injection in Healthy Subjects

Asthma | Atopic Dermatitis | COPD

China
Lumosa Therapeutics Co., Ltd.

Unknown

A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS

Acute Ischemic Stroke

Taiwan, United States
Cognition Therapeutics

Completed

Ascending Dose Study of CT1812 in Healthy Volunteers

Cognitive Impairment

Australia
Boehringer Ingelheim

Completed

Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers

Healthy

Korea, Republic of
Capstone Therapeutics

Completed

A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars

Scar Prevention | Scar Reduction

United States
Catabasis Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers

Healthy

United States
Emergent BioSolutions
National Institutes of Health (NIH)

Completed

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

Anthrax

United States
Portola Pharmaceuticals

Completed

Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote

Healthy

United States
Aridis Pharmaceuticals, Inc.

Completed

Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)

Pneumonia Due to Staphylococcus Aureus

United States, Belgium, France, Spain
Centre for Addiction and Mental Health

Completed

A Dietary Supplement for Early Cigarette Withdrawal (CIGAR)

Nicotine Dependence, Cigarettes, With Withdrawal

Canada
Lumosa Therapeutics Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects (BRIGHT)

Acute Ischemic Stroke
Lumosa Therapeutics Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT

Acute Ischemic Stroke
Zealand Pharma

Active, not recruiting

A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants

Overweight | Healthy Volunteers | Obese

Germany
Novartis Pharmaceuticals
Innovative Medicines Initiative

Terminated

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis

Bronchiectasis

Germany, Spain, United Kingdom, China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

A Study of SYHA1805 in Healthy Adult Subjects

Healthy Subjects
Capstone Therapeutics

Completed

A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars

Scar Prevention | Scar Reduction

United States
Columbia University
Trio Medicines Ltd.

Completed

Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus

Barrett's Esophagus

United States, United Kingdom
University of Virginia
National Institutes of Health (NIH)

Completed

Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication

Peripheral Arterial Disease | Intermittent Claudication

United States
Novartis Pharmaceuticals

Completed

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Breast Cancer

Canada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
Extend Biosciences Inc.
National Institutes of Health (NIH); Pharmaceutical Research Associates; Integrated...

Completed

A Phase 1 Study of EXT608 in Healthy Adults

Safety Issues

United States
JW Pharmaceutical

Completed

Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers

Healthy

Korea, Republic of
University of Rochester

Recruiting

Efficacy of IV Acetaminophen Versus Oral Acetaminophen

Nephrectomy

United States
SamA Pharmaceutical Co., Ltd

Unknown

Clinical Trials to Assess the Efficacy and Safety of HLIM

Acute Bronchitis | Acute Upper Respiratory Tract Infection

Korea, Republic of
Baylor College of Medicine
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

A Randomized, Placebo-controlled, Tourette Syndrome Study.

Tourette Syndrome
Universidad El Bosque, Bogotá

Completed

HYPOCHLOROUS ACID SUBSTANTIVITY AS ANTIPLAQUE AGENT (HOCl-SAP) (HOCl-SAP)

Mouthwashes | Hypochlorous Acid

Colombia
CHU de Quebec-Universite Laval
Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Maisonneuve-Rosemont... and other collaborators

Completed

Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers

HIV | Chlamydia Trachomatis | Neisseria Gonorrhoeae Infection

Benin
Novus Therapeutics, Inc

Completed

Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media

Acute Otitis Media

United States
Shanghai HEP Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers

Hepatitis B， Chronic

China
Shanghai HEP Pharmaceutical Co., Ltd.

Completed

Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers

Hepatitis B， Chronic

China
Hospital Español de Mexico

Withdrawn

Vitamin C to Reduce Vasopressor Dose in Septic Shock (ViCiS)

Sepsis | Septic Shock

Mexico
The University of Hong Kong
Queen Mary Hospital, Hong Kong; Kowloon Hospital, Hong Kong; Castle Peak Hospital and other collaborators

Completed

Berberine as Adjuvant Treatment for Schizophrenia Patients (BER)

Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Metabolic Syndrome x

Hong Kong
Microbicide Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Rectal Microbicide Acceptability, Tolerability and Adherence

HIV Prevention

United States, Malawi, Peru, South Africa, Thailand
Aquilon Pharmaceuticals S.A.

Terminated

Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms (SIROCCO-1)

Covid19

Belgium
Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Recruiting

Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects (XT1061)

Chronic Hepatitis b

China
GlaxoSmithKline

Completed

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Mologen AG

Completed

A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703

Healthy

United States
Postgraduate Institute of Medical Education and...

Completed

RANKL Antibody for Acute Charcot Neuro-osteoarthropathy (DANCN-CKD)

Charcot Joint of Foot

India
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms (Monalisa)

Climacteric Syndrome

Brazil
University of California, Davis

Terminated

Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma

Asthma

United States
AstraZeneca

Completed

AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.

T2DM With NAFLD
Novartis Pharmaceuticals

Completed

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

Cachexia

Switzerland, United States, United Kingdom, Lithuania, Romania

Search clinical trials for: Placebo drug

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations